Processa Pharmaceuticals Inc Share Price

NASDAQ: PCSA

Small Cap

$0.20

+0.01

(+5.70%)

as on September 16, 2025 at 1:29 am IST

$₹

Processa Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
$0.18
Day's Price Range
$0.2
$0.2
10.00%
Downside
52 Week's Low
52 Week's High
$0.15
52-Week Price Range
$1.5
$0.2
25.00%
Downside
650.00%
Upside

Processa Pharmaceuticals Inc share price movements today

Previous Close: $0.19
Open: $0.20
Volume: 2.8M
Day's Low - High: $0.18 - $0.2
52 Week Low - High: $0.15 - $1.5

Processa Pharmaceuticals Inc Historical Returns

1 Month Return: -11.2 %
3 Month Return: -25.76 %
1 Year Return: -85.68 %
3 Year Return: -99.63 %
5 Year Return: 0 %

Processa Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Processa Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.5M

EPS (TTM)

-0.43

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-13.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Processa Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Processa Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Processa Pharmaceuticals Inc	BUY	$9.5M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Processa Pharmaceuticals Inc Stock including INR - Dollar returns

The Processa Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Processa Pharmaceuticals Inc investment value today

Current value as on today

₹19,911

Returns

₹80,089

(-80.09%)

Returns from Processa Pharmaceuticals Inc Stock

₹85,075 (-85.07%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Processa Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Processa Pharmaceuticals Inc. Average target price of $1

Processa Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Processa Pharmaceuticals Inc.

What analysts predicted

80%UPSIDE

Target Price

Current Price

$0.2

Analyzed by

9 Analysts

Target

$1.00

Processa Pharmaceuticals Inc target price $1, a slight upside of 80% compared to current price of $0.2. According to 9 analysts rating.

Processa Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Processa Pharmaceuticals Inc Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-18% versus previous 30 day period

Processa Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	12	-	-
Gross Profit	-4	-2	0	0	0	0	-3	6	0	0
Operating Income	-4	-2	-2	-2	-2	-3	-3	-2	-2	-3
EBITDA	-4	-2	-2	-2	-2	-3	-3	-2	-2	-3
Interest Expense	4	-	-	4	-	-	-	-	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-4	-2	-2	-2	-2	-3	-3	-2	-2	-3
Income Tax Expense	-4	0	2	2	0	0	0	-	-	-
Net Income	-4	-2	-2	-2	-2	-3	-3	-2	-2	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-21.88%	0.00%	0.00%

Processa Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	0	2	-1	-4	-3	-15	-12	-27	-11	-12
EBITDA	0	-2	-1	-3	-3	-5	-11	-19	-11	-11
Interest Expense	-	0	0	0	0	0	0	0	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-2	-2	-1	-4	-3	-15	-11	-27	-11	-11
Income Tax Expense	0	0	0	0	0	-1	0	27	0	-
Net Income	-3	-3	-1	-3	-3	-14	-11	-27	-11	-11
Net Profit Margin	-2957.22%	-2957.22%	-37126.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Processa Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	-2	-2	-2	-3	-3	-2	-2	-3
Operating Cash Flow	-2	-1	-2	-2	-3	-3	-2	-2	-2
Investing Cash Flow	-	0	-	-	-	0	-	-	-
Financing Cash Flow	-	0	0	6	0	0	0	4	6
Change in Cash	-2	-1	-2	4	-3	-2	-1	1	4

Processa Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-1	-3	-3	-14	-11	-27	-11	-11
Operating Cash Flow	0	-1	-3	-2	-3	-8	-9	-8	-11
Investing Cash Flow	0	1	0	-	-	-	-	0	0
Financing Cash Flow	0	2	2	1	17	9	0	6	7
Change in Cash	0	1	-1	-1	14	1	-9	-1	-3

Global Institutional Holdings in Processa Pharmaceuticals Inc

Funds	Holdings
Armistice Capital, LLC	0.14%
Virtu Financial LLC	0.11%
Geode Capital Management, LLC	0.09%
Vanguard Group Inc	0.06%
Sequoia Financial Advisors LLC	0.03%

See all

Insights on Processa Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 72.3% return, outperforming this stock by 159.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 118.7% return, outperforming this stock by 218.3%
NEGATIVE IMPACT
Price Dip
In the last 1 month, PCSA stock has moved down by -12.3%

About Processa Pharmaceuticals Inc

processa pharmaceuticals was founded in october 2017 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. the company is headquartered in hanover, maryland.

Organisation	Processa Pharmaceuticals Inc
Headquarters	7380 Coca Cola Drive, Hanover, MD, United States, 21076
Industry	Industrial Machinery
CEO	Mr. George K. Ng Esq., J.D.
E-voting on shares	Click here to vote

Key Management of Processa Pharmaceuticals Inc

Name	Title
Dr. David Young Ph.D., Pharm.D.	Co-Founder, President of Research and Development & Director
Dr. Sian E. Bigora Ph.D., Pharm.D.	Co-Founder and Chief Development & Regulatory Officer
Mr. Patrick Lin	Co-Founder, Chief Business & Strategy Officer
Ms. Wendy J. Guy	Co-Founder, Chief Administrative Officer & Corporate Secretary
Mr. Russell L. Skibsted M.B.A.	Chief Financial Officer
Dr. Steven Cha M.D.	Senior Vice President of Clinical Research
Mr. George K. Ng Esq., J.D.	CEO & Director

FAQs

What is Processa Pharmaceuticals Inc share price today?

Processa Pharmaceuticals Inc share price today is $0.2 as on September 16, 2025 at 1:29 am IST at the close of the market. Processa Pharmaceuticals Inc share today touched a day high of $0.2 and a low of $0.18.

What is the 52 week high and 52 week low for Processa Pharmaceuticals Inc share?

Processa Pharmaceuticals Inc share touched a 52 week high of $1.5 on December 10, 2024 and a 52 week low of $0.15 on April 17, 2025. Processa Pharmaceuticals Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $0.2,which is 86.67% down from its 52 week high and 33.33% up from its 52 week low.

What is Processa Pharmaceuticals Inc's market capitalisation today?

Processa Pharmaceuticals Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Processa Pharmaceuticals Inc Stock (PCSA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Processa Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Processa Pharmaceuticals Inc Shares that will get you 7.5000 shares as per Processa Pharmaceuticals Inc share price of $0.2 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Processa Pharmaceuticals Inc Stock (PCSA) from India?

Indian investors can start investing in Processa Pharmaceuticals Inc (PCSA) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 8:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Processa Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 8:39 am IST). Based on Processa Pharmaceuticals Inc share’s latest price of $0.2 as on September 16, 2025 at 1:29 am IST, you will get 50.0000 shares of Processa Pharmaceuticals Inc. Learn more about fractional shares .